Answers are grounded in this paper and cite their sources.
We study the hypothesis that the kinetic matrix of two Higgs doubletsis a positive trace of their Yukawa couplings (for canonicallynormalized doublets: that the Gram matrix of the Yukawa couplings isproportional to the identity), and its completion in which the sametrace normalizes all dimension-four bosonic terms. For two groups offermions, each coupled to the two doublets in a common ratio, thekinetic hypothesis fixes tan²β as a ratio of colour-weightedsquared-mass traces; for n such groups its solutions formCPⁿ⁻² with sharp bounds, and the summed squared couplingof each additional scalar is fixed. For additional scalars above thepresent search limits, about $2.0$, $0.4$ and $1.2$~TeV in thealignment limit with degenerate masses, and the relation imposedbetween their mass and 10¹⁶~GeV, it selectstanβ=--,-- and -- for theType~II, lepton-specific and flipped assignments (, and for running masses at MZ). At oneloop the relation is preserved by fermion loops and violated by bosonloops. In the completion, which is the normalization of the spectralaction and of bosons induced by fermion loops, five normalizationsmust coincide at the matching scale. Along the measured two-looptrajectory they coincide only in pairs, at five scales between10^ and 10^~GeV. With the Higgsdoublets as the only scalars, the SU(2) coupling in the trace relationand threshold corrections neglected, matching at10¹³--10¹⁸~GeV givesMₜ=190--$200$~GeV and Mₕ=180--$191$~GeV for one doublet and foreach two-doublet assignment, and Mₕ of at least about~GeV when the top mass is repaired by additional, unobservedYukawa couplings in the trace; matching below $10$~TeV givesmₕ2mₜ at tree level and requires weak and hypercharge tracesfar larger than the known fermions supply. Thesinglet scalar of the Majorana sector, which is known to lower thescalar mass, is not included. We tabulate the normalizations that aconstruction matching onto the Standard Model must reproduce at itsmatching scale.
No takes yet. Share an insight, caveat, or question.
Tejinder P. Singh (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: